Comparison of Three Cardioplegic Solutions - Studies on Myocardial Protection during Ischemia and Reperfusion Performed on the Isolated Heart;Vergleich dreier gängiger Kardioplegielösungen - Untersuchungen am isolierten Herzen zur Myokardprotektion während Ischämie und Reperfusion

Acta Chirurgica Austriaca

Volumn 28, Issue 6, 1996, Pages 346-351

  Podesser, B ^a,c   Zegner, M ^b   Weisser, J ^b   Koci, G ^b   Kunold, A ^b   Hallstrom S ^b   Mallinger, R ^c   Schima, H ^b   Wollenek, G ^a  

^a Univ Klin für Chirurgie   (Austria)

^b LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cardioplegia; Hemodynamics; High energy phosphates; Myocardial protection

Indexed keywords

CARDIOPLEGIC AGENT; OXYGEN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEMODYNAMICS; NONHUMAN; OXYGEN TRANSPORT; RABBIT;

EID: 0030450361     PISSN: 0001544X     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02616282     Document Type: Review

References (33)

1. Bretschneider HJ: Myocardial protection. Thorac Cardiovasc Surg 1980;28:295-302.
2. Sealy WL, Brown IW, Young WG: A report on the use of both extracorporal circulation and hypothermia for open heart surgery. Ann Surg 1958;147:603-606.
3. Bretschneider HJ: Überlebenszeit und Wiederbelebungszeit des Herzens bei Normo- und Hypothermie. Verh Dtsch Ges Kreislaufforsch 1964;30:11-34.
4. Braimbridge M, Chayen J, Bitensky L, Hearse D, Jynge P, Cankovic-Darracott S: Cold cardioplegia or continous coronary perfusion? Report on preliminary clinical experience as assesed cytochemically. J Thorac Cardiovasc Surg 1977;74:900-906.
5. Melrose DG, Dreyer B, Bentall HH, Baker HH, Baker JBE: Electice cardiac arrest. Lancet 1955;2:21-23.
6. Follette D, Mulder D, Maloney J, Buckberg G: Advances of blood cardioplegia over continous coronary perfusion or intermittent ischemia. J Thorac Cardiovasc Surg 1978;76:604-617.
7. Acar C, Partington M, Buckberg G: Studies of controlled reperfusion after ischemia. XIX. Reperfusate composition: Benifits of blood cardioplegia over Fluosol DA cardioplegia during regional reperfusion - Importance of including blood components in the initial reperfusate. J Thorac Cardiovasc Surg 1991;101:284-293.
8. Buckberg GD: Antegrade/retrograde blood cardioplegia to ensure cardioplegic distribution: operative techniques and objectives. J Card Surg 1989;4:216-238.
9. Buckberg GD: Update on current techniques of myocardial protection. Ann Thorac Surg 1995;60:805-814.
10. Bodenhamer R, DeBoer L, Geffin G, O'Keefe D, Aretz T, Haas G, Daggett W: Enhanced myocardial protection during ischemic arrest. Oxygenation of a crystalloid cardioplegic solution. J Thorac Cardiovasc Surg 1983;85:769-780.
11. Oppell von U, King L, Toit du E, Owen P, Reichart B, Opie L: Effect of oxygenation and consequent ph changes on the efficacy of St. Thomas' Hospital cardioplegic solution. J Thorac Cardiovasc Surg 1991;102:396-404.
12. Barner H: Blood Cardioplegia: A review and comparison with crystalloid cardioplegia. Ann Thorac Surg 1991;52:1354-1367.
13. Iverson L, Young N, Ennix C, Ecker R: Myocardial protection: A comparison of cold blood and cold crystalloid cardioplegia. J Thorac Cardiovasc Surg 1984;87:509-516.
14. Axford-Gatley R, Wilson G, Feindel C: Comparison of blood-based and asanguineous cardioplegic solutions administered at 4 °C. An ultrastructural morphometric study in the dog. J Thorac Cardiovasc Surg 1990;100:400-409.
15. Li GC, Vasques LA, Gallagher KP, Lucchesi BR: Myocardial protection with preconditioning. Circulation 1990;82:609-619.
16. Grover GJ, Sleph PG, Dzwonczyk S: Role of myocardial ATP-sensitive potassium channels in mediating preconditioing in the dog heart and their possible interaction with adenosine A1-receptors. Circulation 1992;86:1310-1316.
17. Murry C, Richard V, Riemer K, Jennings R: Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circulation Res 1990;66:913-931.
18. Podesser B, Hausleithner V, Seitelberger R, Wollenek G, Wolner E, Steiert H: New developments in the isolated working heart: A comparison of neonatal, immature and adult rabbits after sixty minutes of ischemia in respect to hemodynamic and biochemical parameters. J Pharm Tox Meth 1993;30:189-197.
19. Strehler BL: ATP and CP determination with luciferase: methods of enzymatic analysis, in Bergmeyer HU (ed): Methoden der enzymatischen Analyse. New York, Academia Press, 1970, pp 236-250.
20. Fürst W, Hallström S: Simultaneus determination of myocardial nucleotides, nucleosides, purine bases and creatin phosphate by ionpair high performance liquid chromatography. J Chromatogr 1992;578:39-44.
21. Bical O, Gerharth M, Gaillard D, Comas J, Landais P, Fischer M, Trivin F. Vanetti A: Comparison of different types of cardioplegia and reperfusion on myocardial metabolism and free radical activity. Circulation 1991;84 (suppl III): 375-379.
22. Goldstein J, Salter D, Murphy C, Abd-Elfattah A, Morris J, Wechsler A: The efficacy of blood versus crystalloid coronary sinus cardioplegia during global myocardial ischemia. Circulation 1986;74 (supp III): 99-104.
23. Holman W, Walter V, Spruell R, Digerness S, Pacifico A: Effect of hemoglobin concentration on oxyhemoglobin dissociation during hypothermic blood cardioplegic arrest. J Thorac Cardiovasc Surg 1994;108:664-671.
24. Marshall R: Correlation of contractile dysfunction with oxidative energy production and tissue high energy phosphate stores during partial coronary flow distribution in rabbit heart. J Clin Invest 1988;82:86-95.
25. Braunwald E, Rutherford JD: Reversible ischemic left ventricular dysfunction: Evidence for the "hibernating myocardium." J Am Coll Cardiol 1986;8:1467-1470.
26. Rosenkranz E, Okamoto F, Bukberg G, Vinthen-Johansen J, Allen B, Leaf J, Bugyi H, Young H, Barnard J: Studies of controlled reperfusion after ischemia II. Biochemical studies: Failure of tissue adenosine triphosphate levels to predict recovery of contractile function after controlled reperfusion. J Thorac Cardiovasc Surg 1986;92:488-501.
27. Chong Y, Cottier D, Gavin J: Myocardial protection during prolonged ischemic cardiac arrest: experimental evaluation of three crystalloid cardioplegic solutions. J Cardiovasc Surg 1994;35:35-44.
28. Becker B, Massoudy P, Permanetter B, Raschke P, Zahler S: Mögliche Bedeutung von Sauerstoffradikalen für den Reperfusionsschaden. Z Kardiol 1993:82 (suppl 5): 49-58.
29. Piper M, Noll T, Siegmund B: Mitochondrial function in the oxygen depleted and reoxygenated myocardial cell. Cardiovasc Res 1994;28:1-15.
30. Gauduel Y, Duvellerov MA: Role of oxygen radicals in cardiac injury due to reoxygenation. J Mol Cell Cardiol 1984;16:459-470.
31. Hess ML: Proton and free oxygen radical interaction with the calcium transport system of the cardiac sarcoplasmatic reticulum. J Mol Cell Cardiol 1981;13:767-772.
32. Engler R, Covell JW: Granulocytes cause reperfusion ventricular dysfunction after 15-minute ischmia in the dog. Cir Res 1987;61:20-28.
33. Juneau CF. Ito BR, del Balzo U, Engler RL: Severe neutrophil depletion by leukocyte filters or cytotoxic drug does not improve the recovery of contractile function in the porcine stunned myocardium. Cardiovasc Res 1993;24:720-727.